Switzerland · 
Who invested in ObsEva?
ObsEva's investors include New Enterprise Associates, OrbiMed, Sofinnova Partners, Sofinnova Investments and Novo Holdings A/S, and 2 more on record.
20142015
$33MSeries A$60MSeries BSwitzerland · Series B startup
Who invested in ObsEva
2 rounds we have observed, with the 7 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$93Mraised across 2 rounds since 2013, from 2 sources
$33MSeries A$60MSeries B
- Latest round
- Series B, $60MNov 2015
- Step-upi
- 1.8×
- Investors
- 7
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $33M Aug 2013
- Biggest round
- $60M Series B · Nov 2015
- Between rounds
- 2.3 years from the last two
The rounds
- Nov 2015Series B$60M5 new
From a historical funding record
- Aug 2013
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Novo Holdings A/SGrowth equity1round
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists ObsEva as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about ObsEva
How much has ObsEva raised?
ObsEva has raised $93M across 2 rounds since 2013.
When did ObsEva last raise?
ObsEva's most recent round was a Series B of $60M in Nov 2015.
What was ObsEva's biggest round?
Its most recent round, $60M in Nov 2015, is also its largest on record.
Who backed ObsEva first?
ObsEva's first round on record, in Aug 2013, was backed by Sofinnova Investments and Novo Holdings A/S.
What stage is ObsEva at?
ObsEva's latest named round is a Series B, in Nov 2015.
Where is ObsEva based?
ObsEva is based in Switzerland.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.